Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults

A fully liquid MenACWY-CRM vaccine presentation has been developed, modifying the meningococcal serogroup A (MenA) component from lyophilized to liquid. The safety and immunogenicity of the liquid presentation at the end of the intended shelf-life (aged for 24 or 30 months) were compared to the lice...

Descripción completa

Detalles Bibliográficos
Autores principales: Díez-Domingo, Javier, Tinoco, Juan Carlos, Poder, Airi, Dinleyici, Ener Cagri, Nell, Haylene, Salamanca de la Cueva, Ignacio, Ince, Tolga, Moreira, Edson Duarte, Ahmed, Khatija, Luz, Kleber, Kovshirina, Yulia, Medina Pech, Carlos Eduardo, Akhund, Tauseefullah, Romolini, Valerio, Costantini, Marco, Mzolo, Thembile, Kunnel, Barry, Lechevin, Isabelle, Aggravi, Marianna, Tiberi, Paola, Narendran, K, García-Martínez, Juan-Antonio, Basile, Venere, Fragapane, Elena, Lattanzi, Maria, Pellegrini, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Meningococcal – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966988/
https://www.ncbi.nlm.nih.gov/pubmed/34614379
http://dx.doi.org/10.1080/21645515.2021.1981085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966988/
https://www.ncbi.nlm.nih.gov/pubmed/34614379
http://dx.doi.org/10.1080/21645515.2021.1981085

Ejemplares similares